SEC Form 4 · accession 0001638599-17-000348
iBio, Inc. · IBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McKey Jr.
Director
Period of report
Sep 5, 2014
Accepted (ET)
Apr 5, 2017 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420720
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.49 | Sep 5, 2014 | A | 60,000 | A | — | Sep 5, 2024 | Common Stock | 60,000 | 490,000 | D |
| Stock Option (right to buy)F2 | $1.72 | Sep 4, 2015 | A | 100,000 | A | — | Sep 4, 2025 | Common Stock | 100,000 | 590,000 | D |
Explanation of responses
- F1(1) Vesting starts 7/1/2014, in equal annual installments over three years.
- F2(2) Vesting starts 7/1/2015, in equal annual installments over three years.